HB6705: Effective Screening and Testing for Tuberculosis Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes.
Plain-language summary
This bill would direct the federal Health and Human Services Secretary to speed up approval for certain new tuberculosis tests by treating them as breakthrough devices. It would require blood banks, tissue banks, and similar facilities that screen donors to test for both active and latent tuberculosis. Latent tuberculosis means the infection is present but dormant and not contagious. The bill was introduced by four members of Congress and is currently awaiting review.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB6705: Effective Screening and Testing for Tuberculosis Act
Upcoming hearings & events
Sponsors
John Moolenaar
Primary SponsorCo-sponsors (3)
Debbie Dingell
Luis Correa
Bill Huizenga